Why is Novartis India falling/rising?

As of 05-Aug, Novartis India Ltd is experiencing a decline in its stock price, currently at Rs 943.65, which reflects a decrease of Rs 26.1 or 2.69%. The stock has underperformed its sector by 1.74% today, reaching an intraday low of Rs 938, which is a drop of 3.27%. Over the past week, the stock has decreased by 5.45%, and over the past month, it has fallen by 9.45%. Although it has shown positive returns year-to-date at 2.59%, its one-year performance is notably poor, with a decline of 17.43%. The stock is currently trading above its 100-day and 200-day moving averages but below its 5-day, 20-day, and 50-day moving averages. There is a notable increase in investor participation, with delivery volume rising by 73.33% against the 5-day average, indicating some interest despite the price drop.
In the broader market context, Novartis India’s recent performance contrasts sharply with the Sensex, which has only declined by 0.77% over the past week and 3.26% over the past month. This indicates that the stock is underperforming relative to the benchmark index. The year-to-date performance of the stock is also lagging behind the Sensex, which has increased by 3.29% during the same period. The lack of available positive or negative factors in the dashboard limits the understanding of specific catalysts affecting the stock's movement, but the overall trend suggests that investor sentiment may be cautious, contributing to the stock's decline.